106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2016 All rights reserved
Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care.
It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be
considered exclusive of other methods of care reasonably directed at obtaining the same results. e
ultimate judgment concerning the propriety of any course of conduct must be made by the clinician
aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated with
the distributor of this clinical reference tool.
AGAULC16082d
Source
Dassopoulos T, Cohen R, Scherl E , Schwartz R, Kosinski L , Regueiro M. Ulcerative Colitis
CLINICA L CAR E PATHWAY. Available at: http://campaigns.gastro.org/algorithms/
UlcerativeColitis/index.html
Abbreviations
5ASA, 5-aminosalicylic acid (mesalamine); 6-TGN, 6-thioguanine; AGA, American
Gastroenterological Association; CBC, complete blood count; CMP, comprehensive metabolic
panel; CMV, cytomegalovirus; CRP, C-reactive protein; CSA, cyclosporine; DVT; deep vein
thrombosis; ESR, erythrocyte sedimentation rate; NSAID, non-steroidal anti-inflammatory
drug ; TNF, tumor necrosis factor
Visit gastro.org/guidelinesapp to learn about the AGA Clinical Guidelines App.
Available for download on the iTunes and Google Play Store.
AGA Institute Guideline on the
Identification, Assessment and Initial Medical Treatment of
Ulcerative Colitis